Menezes MP, Waddell L, Lenk GM, et al. Whole exome sequencing identifies three recessive FIG4 mutations in an apparently dominant pedigree with Charcot-Marie-Tooth disease. Neuromuscul Disord. 2014;24(8):666-70. doi:10.1016/j.nmd.2014.04.010
Naetar N, Soundarapandian V, Litovchick L, et al. PP2A-mediated regulation of Ras signaling in G2 is essential for stable quiescence and normal G1 length. Mol Cell. 2014;54(6):932-45. doi:10.1016/j.molcel.2014.04.023
Guancial EA, Werner L, Bellmunt J, et al. FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder. Cancer Med. 2014;3(4):835-44. doi:10.1002/cam4.262
Garraway LA. A Notch for noncoding RNA in melanoma. N Engl J Med. 2014;370(20):1950-1. doi:10.1056/NEJMcibr1402173
Helman E, Lawrence MS, Stewart C, Sougnez C, Getz G, Meyerson M. Somatic retrotransposition in human cancer revealed by whole-genome and exome sequencing. Genome Res. 2014;24(7):1053-63. doi:10.1101/gr.163659.113
Ott PA, Fritsch EF, Wu CJ, Dranoff G. Vaccines and melanoma. Hematol Oncol Clin North Am. 2014;28(3):559-69. doi:10.1016/j.hoc.2014.02.008
Rajasagi M, Shukla SA, Fritsch EF, et al. Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia. Blood. 2014;124(3):453-62. doi:10.1182/blood-2014-04-567933
Strazisar M, Cammaerts S, Ven K, et al. MIR137 variants identified in psychiatric patients affect synaptogenesis and neuronal transmission gene sets. Mol Psychiatry. 2015;20(4):472-81. doi:10.1038/mp.2014.53
Deelen P, Menelaou A, van Leeuwen EM, et al. Improved imputation quality of low-frequency and rare variants in European samples using the ’Genome of The Netherlands’. Eur J Hum Genet. 2014;22(11):1321-6. doi:10.1038/ejhg.2014.19
Talwalkar A, Liptrap J, Newcomb J, et al. SMaSH: a benchmarking toolkit for human genome variant calling. Bioinformatics. 2014;30(19):2787-95. doi:10.1093/bioinformatics/btu345